Connection

Christopher Wisniewski to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Christopher Wisniewski has written about Clinical Trials, Phase III as Topic.
Christopher Wisniewski
Connection Strength
0.081
Clinical Trials, Phase III as Topic
  1. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome. Ann Pharmacother. 2010 Apr; 44(4):658-67.
    View in: PubMed
    Score: 0.081
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.